Semaglutide as a promising antiobesity drug

Christou, GA; Katsiki, N; Blundell, J; Fruhbeck, G; Kiortsis, DN

Kiortsis, DN (reprint author), Univ Ioannina, Sch Med, Ioannina 45110, Greece.

OBESITY REVIEWS, 2019; 20 (6): 805

Abstract

Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) with a long elimination half-life, allowing subcutaneous (sc) administration once......

Full Text Link